Aduro Biotech (Aduro), a Triton launched company formed in 2010, stays at the forefront of discovery, development and commercialization of immunotherapies, alone or in combination; that make transformative advances in the treatment of challenging diseases.
FRX Polymers, Inc.
FRX Polymers, Inc., a (formed by Triton in 2007) manufactures Nofia® polyphosphonates - fire resistant plastics. Nofia products are fully transparent, high flowing and, due to their high phosphorus content, are inherently flame retardant.
Fluence specializes in developing energy-efficient wastewater treatment solutions. The company’s innovative Membrane Aerated Biofilm Reactor (MABR) technology is installed at sites around the world.
Sensera is an integrated, fast turnaround client-specific designer and manufacturer of specialized high performance microsensors and micro-fabricated components for the Healthcare, Industrial, Defense and Aerospace markets.
Featured Incubated Products
A Plug and Play ‘Sensitivity Amplifier’ that enables chemical sensors for threat and contraband detection.
MEMS Sensors & Manufacturing
Sensera designs, engineers and manufactures MEMS-based sensors and other devices for industrial, medical and defense applications.
(Fiber Reinforced Aluminum)
Triton FRA Composites is a fiber reinforced aluminum composite that offers light weight and high strength alternatives to heavy steel for bearing applications.
Triton Systems New Company Video
To celebrate Triton's 25 Years in Busines, Triton launched a new video showcasing it's accomplishments, technologists and the vision of the company for the next generation of innovation. To view: https://www.youtube.com/watch?v=rOETFI7EJ3k
Mining Industry is Adopting Sensera’s Location Awareness Solutions as a Critical Capability for the Digital Mine
WOBURN, MA, March 18, 2018: : Sensera recently announced an exclusive supply agreement between its wholly owned subsidiary nanotron Technologies GmbH (nanotron) and SMARTBOW GmbH, a leading provider of farm animal health solutions. This agreement represents the initial go to market strategy for nanotron’s location awareness products in the animal health sector.
Aduro Announces Milestone Achieved under Merck Collaboration for Initiation of Anti-CD27 Phase I Trial in Advanced Solid Tumors
BERKELEY, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ:ADRO) today announced that the company earned a $3.0 million development milestone payment under its worldwide licensing agreement with Merck (known as MSD outside the United States and Canada) for the initiation of a Phase I clinical trial of its anti-CD27 antibody. The Phase 1 trial is designed to evaluate the safety and pharmacokinetics of the anti-CD27 antibody when administered alone and in combination with pembrolizumab in adults with advanced solid tumors.
Fluence awarded contract for innovative reuse water system in California
NEW YORK, April 10, 2018: Fluence Corporation Limited (ASX: FLC) (“Fluence”) announced that it has received a contract to deliver a water treatment reuse system to its customer Rosenblad Design Group (Rosenblad) in California, which is one of the largest water and wastewater treatment markets for Fluence.